Goldman Sachs’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$958K Buy
855,286
+61,900
+8% +$69.3K ﹤0.01% 3873
2025
Q1
$912K Sell
793,386
-185,099
-19% -$213K ﹤0.01% 3864
2024
Q4
$5.98M Sell
978,485
-280,745
-22% -$1.72M ﹤0.01% 2720
2024
Q3
$20.8M Sell
1,259,230
-74,683
-6% -$1.24M ﹤0.01% 1714
2024
Q2
$9.16M Buy
1,333,913
+55,294
+4% +$380K ﹤0.01% 2146
2024
Q1
$12.3M Buy
1,278,619
+238,110
+23% +$2.3M ﹤0.01% 1905
2023
Q4
$8.65M Buy
1,040,509
+583,516
+128% +$4.85M ﹤0.01% 2197
2023
Q3
$3.82M Sell
456,993
-215,196
-32% -$1.8M ﹤0.01% 2667
2023
Q2
$6.2M Buy
672,189
+278,675
+71% +$2.57M ﹤0.01% 2409
2023
Q1
$5.41M Buy
393,514
+194,588
+98% +$2.67M ﹤0.01% 2482
2022
Q4
$3.38M Sell
198,926
-50,343
-20% -$856K ﹤0.01% 2915
2022
Q3
$5.67M Buy
249,269
+50,715
+26% +$1.15M ﹤0.01% 2551
2022
Q2
$3.58M Sell
198,554
-229,533
-54% -$4.14M ﹤0.01% 2963
2022
Q1
$11.4M Buy
428,087
+24,463
+6% +$654K ﹤0.01% 2132
2021
Q4
$11.8M Sell
403,624
-2,856
-0.7% -$83.8K ﹤0.01% 2144
2021
Q3
$26.7M Sell
406,480
-16,403
-4% -$1.08M 0.01% 1512
2021
Q2
$35.2M Sell
422,883
-317,427
-43% -$26.4M 0.01% 1326
2021
Q1
$56.8M Buy
740,310
+534,992
+261% +$41M 0.01% 953
2020
Q4
$18.1M Buy
205,318
+145,264
+242% +$12.8M ﹤0.01% 1633
2020
Q3
$4.43M Sell
60,054
-4,591
-7% -$339K ﹤0.01% 2458
2020
Q2
$4.72M Buy
+64,645
New +$4.72M ﹤0.01% 2366
2019
Q4
Sell
-54,700
Closed -$971K 4331
2019
Q3
$971K Buy
+54,700
New +$971K ﹤0.01% 3265